[Federal Register Volume 67, Number 17 (Friday, January 25, 2002)]
[Notices]
[Pages 3711-3712]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-1847]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee, Subcommittee on Future 
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on 
Vaccine Safety and Communication Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-5 p.m., February 5, 2002,8:30 a.m.-1:15 
p.m., February 6, 2002.
    Place: Hubert H. Humphrey Building, Room 705A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent

[[Page 3712]]

procedures for entrance to the Hubert H. Humphrey Building by non-
government employees. Thus, persons without a government 
identification card should plan to arrive at the building each day 
either between 8 a.m. and 8:30 a.m. or 12:30 p.m. and 1 p.m. 
Entrance to the meeting at other times during the day cannot be 
assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters to be discussed: Agenda items will include: A report 
from the National Vaccine Program Office (NVPO) and the Interagency 
Vaccine Workgroup; a report from the Acting Assistant Secretary for 
Health; a report from the Rotavirus Vaccine Workshop; Thimerasol in 
Vaccines--Followup; discussion of decisions in the face of 
uncertainty; discussions on Bioterrorism Issues, Departmental 
Initiatives, Smallpox Preparedness, & Anthrax Preparedness; an 
update on Vaccine Supply--Report from the NVAC Workgroup; Vaccine 
Safety and Communication Subcommittee report; Immunization Coverage 
Subcommittee report, Pediatric and Adolescent Immunization 
Standards; Future Vaccines Subcommittee report; Rotavirus Vaccine 
Workshop--Report; an update on Immunization Registries; a report on 
Polio Laboratory Containment, an update on Global Polio Eradication; 
reports from Advisory Commission on Childhood Vaccines/Division of 
Vaccine Injury Compensation, Vaccine Related Biological Products 
Advisory Committee/Food and Drug Administration, Advisory Committee 
on Immunization Practices/National Immunization Program/National 
Center for Infectious Diseases.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 2 p.m.-5 p.m., February 5, 2002.
    Place: Hubert H. Humphrey Building, Room 305A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee develops policy options and guides 
national activities that lead to accelerated development, licensure, 
and the best use of new vaccines in the simplest possible 
immunization schedules.
    Matters to be discussed: Agenda items will include a report from 
CDC Consultation on Partially Effective Vaccines for HIV; 
discussions on possible future topics including Pneumococcal Vaccine 
and Varicella in Immunocompromised hosts.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 2 p.m.-5 p.m., February 5, 2002.
    Place: Hubert H. Humphrey Building, Room 705A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters to be discussed: Agenda items will include a report on 
the status of the adult immunization standards and the adolescent 
and child immunization standards; an update on the Mandatory 
Immunization Guidelines Workgroup; and a report on vaccine financing 
issues.
    Name: Subcommittee on Vaccine Safety and Communication.
    Time and Date: 2 p.m.-5 p.m., February 5, 2002.
    Place: Hubert H. Humphrey Building, Room 325A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee reviews issues relevant to vaccine 
safety and adverse reactions to vaccines.
    Matters to be Discussed: Institute of Medicine Vaccine Safety 
Committee final report; Selection of Vaccine Safety Hypotheses for 
Year 2002; discussion of a Possible Alternative Standard for 
Adjudication of VICP Claims for Non-Table Injuries; follow-up to the 
``Workshop on Vaccine Communications''.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria Sagar, Committee 
Management Specialist, NVPO, CDC, 4770 Burford Highway M/S K-77, 
Atlanta, Georgia 30341, telephone 770/488-2040.
    An unavoidable administrative delay meeting the 15-day 
publication requirement.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for ToxicSubstances and Disease Registry.


    Dated: January 18, 2002.
Alvin Hall,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-1847 Filed 1-24-02; 8:45 am]
BILLING CODE 4163-18-P